Neoprobe Corporation and Cardinal Health, Inc. Sign Distribution Agreement for Lymphoseek

DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, announced today an exclusive agreement with Cardinal Health to market and distribute Lymphoseek® through its network of more than 150 nuclear pharmacies.

Back to news